Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?

被引：11
|
作者：
Varghese, Ryan [1 ,2 ]
Kumar, Dileep [1 ,3 ,4 ]
Sharma, Rohit [5 ]
机构：
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Pune 411038, Maharashtra, India
[2] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Dept Clin Pharmacol, Kharghar 410210, Navi Mumbai, India
[3] Univ Calif Davis, Dept Entomol, One Shields Ave, Davis, CA 95616 USA
[4] Univ Calif Davis, UC Davis Comprehens Canc Ctr, One Shields Ave, Davis, CA 95616 USA
[5] Banaras Hindu Univ, Inst Med Sci, Fac Ayurveda, Dept Rasa Shastra & Bhaishajya Kalpana, Varanasi 221005, Uttar Pradesh, India
来源：
HUMAN CELL | 2023年 / 36卷 / 03期
关键词：
SARS-CoV-2; COVID-19; Variants; BF.7; BQ.1; BQ.1.1; XBB.1.5;
D O I：
10.1007/s13577-023-00903-9
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1218 / 1221
页数：4
相关论文
共 32 条
  • [11] Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
    von der Schulenburg, Philippa
    Behrens, Georg M. N.
    Hoffmann, Markus
    Linke, Alexandra
    Nehlmeier, Inga
    Kempf, Amy Madeleine
    Stankov, Metodi
    Luetgehetmann, Marc
    Jahnke-Triankowski, Jacqueline
    Addo, Marylyn M.
    Fischer, Lutz
    Lohse, Ansgar W.
    Poehlmann, Stefan
    zur Wiesch, Julian Schulze
    Sterneck, Martina
    VIRUSES-BASEL, 2024, 16 (12):
  • [12] Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
    Sullivan, David J.
    Franchini, Massimo
    Senefeld, Jonathon W.
    Joyner, Michael J.
    Casadevall, Arturo
    Focosi, Daniele
    JOURNAL OF GENERAL VIROLOGY, 2023, 104 (05)
  • [13] XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
    Carreno, Juan Manuel
    Lerman, Brian
    Singh, Gagandeep
    Abbad, Anass
    Yellin, Temima
    Ehrenhaus, Jordan
    Fried, Miriam
    Nardulli, Jessica R.
    Kang, Hyun Min
    Mulder, Lubbertus C. F.
    Gleason, Charles
    Srivastava, Komal
    Simon, Viviana
    PVI Study Grp, Florian
    Krammer, Florian
    MBIO, 2025,
  • [14] Modeling the SARS-CoV-2 sublineages XBB and BQ.1 in Mexico, considering multiple vaccinations, booster dose, waning immunity and cross-immunity
    de Leon, Ugo Avila -Ponce
    Perez, Angel G. C.
    Avila-Vales, Eric
    ELECTRONIC RESEARCH ARCHIVE, 2024, 32 (02): : 1082 - 1125
  • [15] XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants
    Levy, Matthew E.
    Chilunda, Vanessa
    Heaton, Phillip R.
    Mckeen, Deran
    Goldman, Jason D.
    Davis, Richard E.
    Schandl, Cynthia A.
    Glen, William B.
    Mcewen, Lisa M.
    Cirulli, Elizabeth T.
    Wyman, Dana
    Dei Rossi, Andrew
    Dai, Hang
    Isaksson, Magnus
    Washington, Nicole L.
    Basler, Tracy
    Tsan, Kevin
    Nguyen, Jason
    Ramirez, Jimmy
    Sandoval, Efren
    Lee, William
    Lu, James
    Luo, Shishi
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [16] The SARS-CoV-2 Hydra, a tiny monster from the 21st century: Thermodynamics of the BA.5.2 and BF.7 variants
    Popovic, Marko
    MICROBIAL RISK ANALYSIS, 2023, 23
  • [17] Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants
    Pokorska-Spiewak, Maria
    Pawlowska, Malgorzata
    Ciechanowski, Przemyslaw
    Peregrym, Michal
    Dobrzeniecka, Anna
    Sobolewska-Pilarczyk, Malgorzata
    Franczak, Justyna
    Majda-Stanislawska, Ewa
    Szczepanska, Barbara
    Zaleska, Izabela
    Flisiak, Robert
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (02) : 149 - 154
  • [18] Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study
    Nicolas de Prost
    Etienne Audureau
    Sébastien Préau
    Raphaël Favory
    Aurélie Guigon
    Pierre Bay
    Nicholas Heming
    Elyanne Gault
    Tài Pham
    Amal Chaghouri
    Guillaume Voiriot
    Laurence Morand-Joubert
    Sébastien Jochmans
    Aurélia Pitsch
    Sylvie Meireles
    Damien Contou
    Amandine Henry
    Adrien Joseph
    Marie-Laure Chaix
    Fabrice Uhel
    Diane Descamps
    Malo Emery
    Claudio Garcia-Sanchez
    Charles-Edouard Luyt
    Stéphane Marot
    Frédéric Pène
    Anne-Sophie Lhonneur
    Stéphane Gaudry
    Ségolène Brichler
    Lucile Picard
    Armand Mekontso Dessap
    Christophe Rodriguez
    Jean-Michel Pawlotsky
    Slim Fourati
    Intensive Care Medicine Experimental, 11
  • [19] Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study
    de Prost, Nicolas
    Audureau, Etienne
    Preau, Sebastien
    Favory, Raphael
    Guigon, Aurelie
    Bay, Pierre
    Heming, Nicholas
    Gault, Elyanne
    Pham, Tai
    Chaghouri, Amal
    Voiriot, Guillaume
    Morand-Joubert, Laurence
    Jochmans, Sebastien
    Pitsch, Aurelia
    Meireles, Sylvie
    Contou, Damien
    Henry, Amandine
    Joseph, Adrien
    Chaix, Marie-Laure
    Uhel, Fabrice
    Descamps, Diane
    Emery, Malo
    Garcia-Sanchez, Claudio
    Luyt, Charles-Edouard
    Marot, Stephane
    Pene, Frederic
    Lhonneur, Anne-Sophie
    Gaudry, Stephane
    Brichler, Segolene
    Picard, Lucile
    Dessap, Armand Mekontso
    Rodriguez, Christophe
    Pawlotsky, Jean-Michel
    Fourati, Slim
    INTENSIVE CARE MEDICINE EXPERIMENTAL, 2023, 11 (01)
  • [20] Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of breakthrough infections in haemodialysis patients
    Platen, Louise
    Liao, Bo-Hung
    Tellenbach, Myriam
    Cheng, Cho-Chin
    Holzmann-Littig, Christopher
    Christa, Catharina
    Daechert, Christopher
    Kappler, Verena
    Bester, Romina
    Werz, Maia Lucia
    Schoenhals, Emely
    Platen, Eva
    Eggerer, Peter
    Treguer, Laetitia
    Kuechle, Claudius
    Schmaderer, Christoph
    Heemann, Uwe
    Keppler, Oliver T.
    Renders, Lutz
    Braunisch, Matthias Christoph
    Protzer, Ulrike
    CLINICAL KIDNEY JOURNAL, 2023, 16 (12) : 2447 - 2460
1234